title: Strattera: ups, downs, and emerging uses.
abstract: Although overall prescribing of atomoxetine hydrochloride (HCI) (Strattera) continues to decline, recent anecdotal reports suggest emerging uses of the product in combination therapy. In this article we examine trends in atomoxetine (HCI) prescribing as well as use in combination with other psychotropic classes. An expert commentary is provided on the data.
authors: Ms. Cascade is Vice President, Strategic Research and Safety, Quintiles Inc., Falls Church, Virginia.
authors: Elisa F
authors: EF
authors: Cascade
authors: Amir H
authors: AH
authors: Kalali
authors: David
authors: D
authors: Feifel